1 Patent
- US121281042024Drug Delivery Systems Comprising a Neurotrophic Agent, an Apoptosis Signaling Fragment Inhibitor (FAS) or FAS Ligand (FASL) Inhibitor, a Tumor Necrosis Factor-alpha (tnf-alpha) or TNF Receptor Inhibitor, a Mitochondrial Peptide, an Oligonucleotide, a Chemokine Inhibitor, or a Cysteine-aspartic Protease Inhibitor
CELLA THERAPEUTICS, LLC
0 cites